Quaker Chemical vs Ingevity
Quaker Chemical reported revenue of $1.9 billion in fiscal 2025, 1.6 times Ingevity's $1.2 billion in fiscal 2025. Quaker Chemical's revenue grew 2.7% in its latest year, and Ingevity's fell 2.7%. Quaker Chemical had an operating margin of 2.8%, against 35.9% at Ingevity. Free cash flow was $81 million at Quaker Chemical and $274 million at Ingevity.
Side by side
| Quaker Chemical | Ingevity | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $1.9B | $1.2B |
| Revenue growth | 2.7% | −2.7% |
| Revenue growth a year, last 5 years | 5.9% | −0.8% |
| Gross margin | 36.0% | 39.5% |
| Operating margin | 2.8% | 35.9% |
| Net margin | −0.1% | −14.3% |
| Free cash flow | $81M | $274M |
| Free cash flow margin | 4.3% | 23.4% |
| Return on capital | 1.3% | 24.6% |
| Net debt to EBITDA | 6.1x | 2.1x |
| Dividends and buybacks | $76M | $56M |
| Change in diluted share count | −2.2% | −0.3% |
| Last close | $154.87 | $71.03 |
| P/E at the last close | 27.6× | 47.4× |
| Insider trades, last 12 months | sold $207,544 | sold $1.8 million |
| Piotroski F-score | 5 of 9 | 6 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
Quaker ChemicalIngevity
Operating margin
Percent of revenue
Quaker ChemicalIngevity
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Quaker ChemicalIngevity
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Quaker Chemical and Ingevity pages.